David P Meeker Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

RYTM Quotes by TradingView

David P Meeker is President and CEO of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 174,605 shares of RYTM, which is worth approximately $9.8 Million. The most recent transaction as insider was on Mar 19, 2024, when has been sold 45,494 shares (Common Stock) at a price of $39.22 per share, resulting in proceeds of $1,784,274. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 175K
0% 3M change
56.83% 12M change
Total Value Held $9.8 Million

David P Meeker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2024
SELL
Open market or private sale
$1,784,274 $39.22 p/Share
45,494 Reduced 20.67%
174,605 Common Stock
Feb 16 2024
BUY
Grant, award, or other acquisition
-
99,000 Added 31.02%
220,099 Common Stock
Feb 01 2024
SELL
Open market or private sale
$196,506 $45.06 p/Share
4,361 Reduced 3.48%
121,099 Common Stock
Feb 01 2024
BUY
Exercise of conversion of derivative security
-
14,125 Added 10.12%
125,460 Common Stock
Mar 30 2021
BUY
Open market or private purchase
$201,700 $20.17 p/Share
10,000 Added 8.24%
111,335 Common Stock

Also insider at

TRVI
Trevi Therapeutics, Inc. Healthcare
MYOK
MyoKardia Inc
Director
DPM

David P Meeker

President and CEO
Brisbane, CA

Track Institutional and Insider Activities on RYTM

Follow RHYTHM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RYTM